Achyut Healthcare Management Change
Achyut Healthcare re-appointed Jigen J. Modi as Executive Director and Sonu L. Jain and Rutvik S. Thakkar as Independent Directors for 60-month terms.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
21 announcements
Achyut Healthcare re-appointed Jigen J. Modi as Executive Director and Sonu L. Jain and Rutvik S. Thakkar as Independent Directors for 60-month terms.
Achyut Healthcare Limited has submitted its 31st Annual Report for the financial year 2025-2026. The Annual General Meeting is scheduled for 29th September, 2026.
Achyut Healthcare's board approved the AGM notice for September 29, 2026, and re-appointed the Managing Director and two Independent Directors for five-year terms.
Achyut Healthcare announces the re-appointment of its Managing Director and two Independent Directors, and schedules its 31st Annual General Meeting for September 29, 2026.
Achyut Healthcare Ltd reported revenue from operations of ₹3.1 Cr (+0.0% YoY) and net profit of ₹0.1 Cr (+0.0% YoY) for Q1 FY27.
Achyut Healthcare Limited scheduled a board meeting on August 13, 2026, to consider and approve its unaudited financial results for the quarter ended June 30, 2026.
Achyut Healthcare Ltd filed its quarterly shareholding pattern. The filing includes a note regarding the allotment of 58 lakh equity shares.
Achyut Healthcare Ltd filed its quarterly shareholding pattern as per Regulation 31. The report discloses a pending allotment of 5.8 million shares for listing approval.
Achyut Healthcare approved its amalgamation with Zenith Healthcare Limited. The merger aims to consolidate pharmaceutical operations and enhance marketing capabilities under a unified group structure.
Achyut Healthcare allotted 58 lakh shares at ₹6/share, raising ₹34.8 Crore. Listing application pending with BSE; corporate action yet to be executed.
Achyut Healthcare allotted 58 lakh shares at ₹6/share, raising ₹3.48 Cr. Listing approval pending; shares not yet credited to allottees.
Achyut Healthcare Limited confirmed zero deviation in the utilization of public and preferential issue proceeds for the half-year. Total funds raised across tranches reached ₹28.01 Crore.
Achyut Healthcare Limited appointed M/s. Mohta Khetawat & Co. as Internal Auditor for FY 2026-27. This move ensures continued regulatory compliance and audit oversight.
Achyut Healthcare Ltd reported a standalone net profit of ₹0.32 Crore for fiscal year 2026. The board also appointed new internal auditors for the upcoming period.
Achyut Healthcare Ltd reported revenue from operations of ₹4.4 Cr (+388.9% YoY) and net profit of ₹0.1 Cr (+0.0% YoY) for Q4 FY26.
Achyut Healthcare reported full-year revenue of ₹11.59 Crore for FY2026. The board approved audited results and appointed M/s. Mohta Khetawat & Co. as internal auditors.
Achyut Healthcare scheduled a board meeting on May 27, 2026, to approve audited financial results. This routine compliance filing sets the timeline for performance disclosure.
Achyut Healthcare Limited submitted its Annual Secretarial Compliance Report for FY2026. The report notes a ₹0.00 Crore penalty paid for late RPT filings.
Achyut Healthcare Ltd received BSE listing approval for 58,00,000 equity shares issued at ₹3.48 Crore. The shares were allotted on a preferential basis to promoters and non-promoters.
Achyut Healthcare Limited submitted its annual disclosure for FY 2025-26, confirming it does not fall under the 'Large Corporate' category. The company reported nil outstanding long-term borrowings as of March 31, 2026, and is therefore not subject to mandatory debt sourcing requirements under SEBI's large corporate framework.
Achyut Healthcare Ltd reported net profit of ₹0 Cr for Q3 FY26.